Merck Germany expands disease education program started in Africa to Asia

Merck, the world’s oldest pharmaceutical and chemical company has widened its global fight against diabetes and thyroid dysfunction from Africa to Asia. Following three years of success providing education and awareness creation and advocacy for medical and pharmacy studentsin African Universities, Merck has extended its Capacity Advancement Program (CAP) initiative to Asia through forging a partnership with University of Indonesia and Maharashtra University to boost diabetes and thyroid dysfunction healthcare capacity in India and Indonesia. 

Merck CAP strategy is a coherent and robust structured initiative that is aligned with national strategies of African and Asian countries to build the healthcare capacity with special focus on non- communicable diseases such as Diabetes, thyroid dysfunction, hypertension and Cancer. This successful strategy will be implemented in collaboration with African and Asian Universities and Ministries of Health.

Stay in the Know!

Sign up for the latest news and information on African Companies and Economy.

By signing up, you agree to receive MoneyInAfrica offers, promotions and other commercial messages. You may unsubscribe at any time.

Leave a Reply